Bio-Rad Laboratories Inc. (BIO) Misses Q1 EPS by 57c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $372.18 --0%
Revenue Growth %: -0.5%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
SYRS, ZVOI, OMID, More
Revenue Growth %: -0.5%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
SYRS, ZVOI, OMID, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $0.23, $0.57 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $509 million versus the consensus estimate of $515 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Check Point Software Technology (CHKP) Reports In-Line Q3 EPS
- World Kinect (WKC) PT Lowered to $39 at BofA Securities
- Kosmos Energy (KOS) Misses Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
